| 1 |
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Giacomo Grasselli et al. · JAMA
Open access114 authors |
6 Apr 2020 |
5,912 |
| 2 |
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al. · New England Journal of Medicine
Open access |
28 Aug 2020 |
5,214 |
| 3 |
Organoid Models and Applications in Biomedical Research
Christodoulos Xinaris, Valerio Brizi, Giuseppe Remuzzi · The Nephron journals/Nephron journals
Open access |
2015 |
3,519 |
| 4 |
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Eric Van Cutsem et al. · Annals of Oncology
Open access |
5 Jul 2016 |
3,512 |
| 5 |
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
Behnood Bikdeli et al. · Journal of the American College of Cardiology
Open access |
17 Apr 2020 |
2,956 |
| 6 |
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al. · Blood
Open access |
29 Jun 2022 |
2,906 |
| 7 |
The Global Burden of Cancer 2013
Christina Fitzmaurice et al. · JAMA Oncology
Open access132 authors |
28 May 2015 |
2,767 |
| 8 |
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Gϋnter von Minckwitz et al. · New England Journal of Medicine
Open access |
5 Dec 2018 |
2,689 |
| 9 |
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi et al. · New England Journal of Medicine
Open access |
24 Feb 2021 |
2,554 |
| 10 |
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Lucio Verdoni, Angelo Mazza, Annalisa Gervasoni et al. · The Lancet
Open access |
13 May 2020 |
2,488 |
| 11 |
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott David Solomon et al. · New England Journal of Medicine
Open access |
Sep 2019 |
2,429 |
| 12 |
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Jeffrey S. Weber et al. · New England Journal of Medicine
Open access |
10 Sep 2017 |
2,249 |
| 13 |
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Jecko V. Thachil, Ning Tang, Satoshi Gando et al. · Journal of Thrombosis and Haemostasis
Open access |
25 Mar 2020 |
2,014 |
| 14 |
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M.M. Eggermont et al. · New England Journal of Medicine
Open access |
15 Apr 2018 |
1,906 |
| 15 |
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
Charles S. Fuchs et al. · JAMA Oncology
Open access |
15 Mar 2018 |
1,835 |
| 16 |
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
Giacomo Grasselli et al. · JAMA Internal Medicine
Open access149 authors |
15 Jul 2020 |
1,747 |
| 17 |
The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions
Roderick J. Hay, Nicole E. Johns, Hywel C Williams et al. · Journal of Investigative Dermatology
Open access |
28 Oct 2013 |
1,710 |
| 18 |
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer et al. · Journal of Clinical Oncology
Open access |
5 Aug 2019 |
1,517 |
| 19 |
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma
Georgina Venetia Long et al. · New England Journal of Medicine
Open access |
10 Sep 2017 |
1,501 |
| 20 |
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
Luca Carsana, Aurelio Sonzogni, Ahmed Medhat Nasr et al. · The Lancet Infectious Diseases
Open access |
8 Jun 2020 |
1,441 |
| 21 |
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Roberto Labianca, Bernard Nordlinger, Giordano Domenico Beretta et al. · Annals of Oncology
Open access |
27 Sep 2013 |
1,428 |
| 22 |
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Georgina Venetia Long et al. · The Lancet
|
31 May 2015 |
1,419 |
| 23 |
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
Caroline Robert et al. · New England Journal of Medicine
Open access |
4 Jun 2019 |
1,412 |
| 24 |
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis
Pietro Amedeo Modesti, Gianpaolo Reboldi, Francesco Paolo Cappuccio et al. · PLoS ONE
ReviewOpen access |
25 Jan 2016 |
1,405 |
| 25 |
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Guillem Argilés, Josep M. Tabernero, Roberto Labianca et al. · Annals of Oncology
Open access |
20 Jul 2020 |
1,399 |
| 26 |
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Kohei Shitara et al. · The Lancet
Open access158 authors |
4 Jun 2018 |
1,338 |
| 27 |
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
Max S. Topp et al. · The Lancet Oncology
|
15 Dec 2014 |
1,277 |
| 28 |
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
Ravindra L. Mehta et al. · The Lancet
|
13 Mar 2015 |
1,164 |
| 29 |
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Axel F. Grothey et al. · New England Journal of Medicine
Open access |
28 Mar 2018 |
1,155 |
| 30 |
Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial
Andrew J Davidson et al. · The Lancet
Open access |
5 Nov 2015 |
1,136 |
| 31 |
Mapping the human genetic architecture of COVID-19
COVID-19 Host Genetics Initiative et al. · Nature
Open access3,896 authors |
8 Jul 2021 |
1,130 |
| 32 |
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
Reinhard Dummer, Paolo A. Ascierto, Helen J Gogas et al. · The Lancet Oncology
Open access |
21 Mar 2018 |
1,040 |
| 33 |
Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Paolo A. Ascierto et al. · The Lancet Oncology
|
30 Jul 2016 |
1,027 |
| 34 |
Chronic kidney disease
Paola Romagnani, Giuseppe Remuzzi, Richard J. Glassock et al. · Nature Reviews Disease Primers
ReviewOpen access |
22 Nov 2017 |
1,008 |
| 35 |
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Christopher J L Murray et al. · The Lancet
Open access366 authors |
21 Jul 2014 |
998 |
| 36 |
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Vittorio Pengo et al. · Blood
Open access |
12 Jul 2018 |
821 |
| 37 |
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions
Lorenz Räber et al. · European Heart Journal
Open access |
16 May 2018 |
763 |
| 38 |
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
Olivia Pagani et al. · New England Journal of Medicine
Open access |
Jun 2014 |
756 |
| 39 |
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson et al. · Blood
Open access |
18 Jul 2014 |
746 |
| 40 |
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
George L. Bakris, Rajiv Agarwal, Juliana C.N. Chan et al. · JAMA
Open access |
Sep 2015 |
707 |
| 41 |
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
Prudence A. Francis et al. · New England Journal of Medicine
Open access |
4 Jun 2018 |
694 |
| 42 |
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
Lorenzo D’Antiga · Liver Transplantation
|
20 Mar 2020 |
686 |
| 43 |
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
Georgina Venetia Long et al. · Annals of Oncology
Open access |
3 May 2017 |
668 |
| 44 |
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study
Bogdan Ene‐Iordache et al. · The Lancet Global Health
Open access |
21 Apr 2016 |
665 |
| 45 |
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial
Ziad A. Ali, Akiko Maehara, Philippe Généreux et al. · The Lancet
|
30 Oct 2016 |
663 |
| 46 |
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
Anthony Jake Demetris et al. · American Journal of Transplantation
Open access |
7 Jun 2016 |
653 |
| 47 |
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger et al. · Blood Cancer Journal
Open access |
9 Feb 2018 |
650 |
| 48 |
Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013
Hmwe Hmwe Kyu et al. · Archives of Pediatrics and Adolescent Medicine
Open access157 authors |
26 Jan 2016 |
641 |
| 49 |
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Zhaohui Gu et al. · Nature Genetics
Open access |
7 Jan 2019 |
631 |
| 50 |
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Marina Chiara Garassino et al. · The Lancet Oncology
Open access |
12 Jun 2020 |
624 |